Cerebral ischaemia of the immature brain may result in cavitating periventricular leucomalacia (PVL), an important association of cerebral palsy. Hypoxanthine measured by high performance liquid chromatography was used as a marker of peripartum hypoxia and ischaemia in 116 infants at risk of PVL. PVL was detected by ultrasound. The 81 infants who were unaffected had median (range) gestation of 30 weeks (24-32), weight of 1336 g (724-3790), and a plasma hypoxanthine concentration of 7-8 iimol/l (2.4-48.9). The seven infants who had cavitating PVL had a median gestation of 28 weeks (26-30), weight of 1165 g (682-1860), and a hypoxanthine concentration of 31-9 ,tmol/l (7-1-149). Cavitating PVL was significantly dependent only on hypoxanthine when controlling for the effects of weight and gestation. This suggests that peripartum hypoxia-ischaemia may be one of the aetiological factors in cavitating PVL. Oxidation of hypoxanthine during reperfusion generates free radicals which may contribute to the tissue destruction of PVL. The association of hypoxia-ischaemia with PVL suggests that PVL may be modified by reducing free radical activity.
G A B Russell, G Jeffers, R W I Cooke Abstract Cerebral ischaemia of the immature brain may result in cavitating periventricular leucomalacia (PVL), an important association of cerebral palsy. Hypoxanthine measured by high performance liquid chromatography was used as a marker of peripartum hypoxia and ischaemia in 116 infants at risk of PVL. PVL was detected by ultrasound. The 81 infants who were unaffected had median (range) gestation of 30 weeks (24) (25) (26) (27) (28) (29) (30) (31) (32) , weight of 1336 g (724-3790), and a plasma hypoxanthine concentration of 7-8 iimol/l (2.4-48.9). The seven infants who had cavitating PVL had a median gestation of 28 weeks (26) (27) (28) (29) (30) , weight of 1165 g (682-1860), and a hypoxanthine concentration of ,tmol/l (7-1-149 To test the hypothesis that an increase in hypoxanthine (as a marker of hypoxia) is associated with PVL, we have examined an 'at risk' population of preterm infants by measuring plasma hypoxanthine concentrations at birth and relating these to the subsequent development of cavitating PVL. We have assumed that cavitation represents the severest degree of ischaemic injury and therefore the severity of the hypoxic insult would be more likely to result in increased circulating hypoxanthine.
Patients and methods
Babies between 24 and 32 weeks' gestation admitted to the Regional Neonatal Intensive Care Unit were studied. Plasma hypoxanthine was measured in samples obtained from cord blood or as soon as possible after admission to the unit. Care was taken to ensure that samples were taken by large needle puncture of either cord artery or vein"7 or by an indwelling arterial line or clean venesection. Samples were rapidly separated and stored at -30°C to avoid leakage of erythrocyte hypoxanthine. Haemolysed samples were discarded.
'Serial cranial ultrasound (ATL Ultramark 4 with a 7 5 MHz transducer) was performed from admission and then at least weekly until discharge. Parenchymal echodensities (of equivalent echodensity to the choroid plexus) seen in both coronal and parasagittal planes were regarded as precavitating PVL. Three groups of echolucencies were identified: porencephaly (lucency widely communicating with the ventricle), cavitating PVL (single or multiple lucencies occurring 2-3 mm from the ventricular wall), and porencephaly with associated PVL (porencephaly with surrounding noncommunicating lucencies either single or multiple occurring 2-3 mm from the porencephalic cavity wall).
Hypoxanthine [26] [27] [28] [29] [30] in table 2 and the figure demonstrates the plot 1165 of hypoxanthine concentrations for each group.
682-1860
An increased concentration of hypoxanthine 31 9: within two hours of birth, thought to indicate 7-1-142-9
antenatal hypoxia, '6 27 [tmol/l (2-4-68-3) and the sampling time was 78 min (0-380) (see figure) .
Discussion
Events such as antepartum haemorrhage and clinical perinatal asphyxia have been associated with subsequent development of PVL,>'2 and parenchymal echodensities detected by ultrasound may appear within three days of birth,' suggesting that many cases are related to peripartum events. PVL is a manifestation of cerebral hypoxia-ischaemia,28 and an increased concentration of plasma hypoxanthine is a biochemical marker of peripartum hypoxia.1S18 The association we have found between increased early plasma hypoxanthine and the development of PVL gives indirect evidence to support the hypothesis that cerebral hypoxia-ischaemia may induced PVL in preterm infants.
There is conflicting evidence for an association between increased concentrations of plasma hypoxanthine and adverse clinical outcome in term babies. Increased cord hypoxanthine or hypoxanthine excretion is found in asphyxiated babies with a reduced 'optimality score '16 or abnormal neurological signs during the first week of life but there is considerable overlap with unaffected babies.'6 18 Neurological assessment at 2 years could not be correlated with cord hypoxanthine in term babies29 but we are not aware of any evidence for preterm babies. The fetal cerebral oxygen uptake rapidly decreases with falling arterial oxygen saturation, especially in combination with acidaemia,30 and so the effect of global hypoxaemia on the vulnerable periventricular watershed zones could affect the fetal and preterm brain more than the term infant with more developed periventricular anastamoses. '3 Our study may have underestimated any association between increased plasma hypoxanthine and PVL because delay in sampling (including outborn babies) was unavoidable in many babies and also because subsequent postnatal hypoxic-ischaemic insults after the admission sampling would not have been detected by hypoxanthine measurements: any increase due to birth asphyxia might have returned to normal giving a false negative association with PVL. On the other hand normal concentrations detected in babies without PVL might have been due to delayed sampling. We found no correlation between sample time and hypoxanthine concentration and this suggests that in the noncavitating group the normal value of hypoxanthine was not due to delayed sampling. The half life of plasma hypoxanthine is three minutes in rabbits3' and 40 minutes in pigs after a hypoxic-ischaemic episode32; in term babies increased concentrations may be detected for two hours after asphyxia'6 27 and in preterm babies increased values have persisted for 24 hours after an hypoxic episode.'4 Plasma hypoxanthine is likely to be trapped in tissues because of inadequate tissue perfusion and circulation; increased values may therefore be detected for some time after the hypoxic insult, until adequate circulation is re-established. This may explain the marked increase in hypoxanthine (142-9 ,umol/l) at seven hours in one baby in the PVL group, despite establishing adequate oxygenation and blood pressure after an emergency caesarean section for footling breech presentation (table 2, case 5).
The degree and timing of the hypoxic episode would influence the magnitude and duration of hypoxanthine increases. An insult occurring in the peripartum period may not therefore have been detected by admission sampling of outborn babies at six to eight hours. Two of the lowest values of hypoxanthine in the PVL group were recorded from outborn infants. About half of the babies from our study who developed any form of parenchymal cavitation had evidence of birth asphyxia, evidenced by increased concentrations of hypoxanthine (greater than 2 SD from the mean: 9 5 [tmol/l) within two hours of birth. This would suggest that the hypoxicischaemic insult occurring antenatally might be associated with later development of parenchymal cavitation.
Increased hypoxanthine has been detected after postnatal events such as pneumothorax, mechanical ventilation for severe respiratory distress syndrome, shock, and necrotising enterocolitis (own observations). Global hypoxia increases plasma hypoxanthine (probably arising from organs with a lower threshold for purine degradation, such as the liver and gut) whereas focal ischaemia within an organ, especially the brain with a higher threshold for purine degradation, may not increase systemic plasma hypoxanthine sufficiently to be detectable by remote sampling.33 Plasma hypoxanthine measured in peripheral plasma is therefore a marker of global hypoxia but this is likely to be associated with global cerebral hypoxiaischaemia. Cerebral hypoxia and ischaemia may therefore be a mechanism of parenchymal injury in pneumothorax, severe respiratory distress requiring mechanical ventilation and shock.
In our study, plasma hypoxanthine was only slightly increased in the two groups in which porencephaly was found. This Hypoxanthine is also a free radical generator37
and this recognition has resulted in renewed interest in the hypoxic-ischaemic mechanism of tissue injury. Free radical induced tissue damage has been demonstrated secondary to excessive production of free radicals by the xanthine oxidase-hypoxanthine reaction.22 If hypoxiaischaemia and free radical generation are aetiological factors in ischaemic disorders of the infant brain, this suggests possible strategies for intervention. Prophylactic inhibition of xanthine oxidase in preterm babies at risk of PVL may reduce the free radical generation after reperfusion/reoxygenation and may therefore limit the extent of tissue destruction. Allopurinol and its major active metabolite oxypurinol are specific inhibitors of xanthine oxidase that have been shown to limit tissue damage due to free radical activity. 23 24 Other free radical scavengers may also have a place in ameliorating damage.25 Difficulties would be encountered in antenatal hypoxia, but peripartum and postpartum hypoxic-ischaemic insults may be more amenable to therapeutic intervention.
